De novo renal transplantation after Kaposi sarcoma: Favorable outcome in a patient receiving sirolimus and mycophenolate-based immunosuppression

Case Reports in Dermatology

Volumn 2, Issue 1, 2010, Pages 32-35

  Friedersdorff, F ^a   Giessing, M ^b   Roller, C ^a   Baumunk, D ^a   Deger, S ^a   Budde, K ^a   Liefeldt, L ^a   Hartmann, V ^a   Fuller, T F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Kaposi sarcoma; Kidney transplantation; Mycophenolate mofetil; Remission; Sirolimus

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CHRONIC GRAFT REJECTION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETRANSPLANTATION;

EID: 77958535340     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000306448     Document Type: Article

References (7)

1. Penn I: Kaposi's sarcoma in transplant recipients. Transplantation 1997;64:669-673.
2. Cattani P, Nanni G, Graffeo R, Capuano M, Cerimele F, La Parola IL, Diociaiuti A, Pozzetto U, Cerimele D, Fadda G, Castagneto M: Pretransplantation human herpes virus 8 seropositivity as a risk factor for Kaposi's sarcoma in kidney transplant recipients. Transplant Proc 2000;32:526-527.
3. Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio, Ranieri GE, Gesualdo L, Schena FP, Grandaliano G: Sirolimus for Kaposi's sarcoma in renaltransplant recipients. N Engl J Med 2005;352:1317-1323.
4. Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L: Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int 2008;21:825-832.
5. Wimmer CD, Rentsch M, Crispin A, Illner WD, Arbogast H, Graeb C, Jauch KW, Guba M: The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich. Kidney Int 2007;71:1271-1280.
6. Lebbe C, Euvrard S, Barrou B, Pouteil-Noble C, Garnier JL, Glotz D, Legendre C, Francès C: Sirolimus conversion for patients with posttransplant Kaposi's sarcoma. Am J Transpl 2006;6:2164-2168.
7. Flechner SM, Goldfarb D, Solez K, Modlin CS, Mastroianni B, Savas K, Babineau D, Kurian S, Salomon D, Novick AC, Cook DJ: Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Transplantation 2007;83:883-892.